12:00 AM
May 17, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Status

C225: Began Phase III trial

The company's first Phase III study is examining C225 in combination with radiation therapy in the same tumor type.

ImClone Systems Inc. (IMCL), New York, N.Y....

Read the full 111 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >